Evidence map›Paper›PMID 40614179›Full record

ArticleScience advances2025

Dicer is cleaved by the Leader protease encoded by foot-and-mouth disease virus to promote infection in mammalian cells.

Miguel Rodríguez-Pulido, Miguel Ángel Sanz, Lucía Camacho, Ricardo Ramos, Margarita Sáiz

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miguel Rodríguez-PulidoCentro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.ORCID 0000-0003-2101-8974
Miguel Ángel SanzCentro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.ORCID 0000-0001-6573-883X
Lucía CamachoCentro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.ORCID 0009-0008-8658-5551
Ricardo RamosGenomic Facility, Fundación Parque Científico de Madrid, Madrid, Spain.ORCID 0000-0002-6331-9786
Margarita SáizCentro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.ORCID 0000-0003-3893-7926

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endoribonuclease Dicer is a central component of the posttranscriptional gene silencing mechanism based on RNA interference (RNAi) in eukaryotes. The antiviral role of RNAi in mammalian cells remains controversial while a number of viral suppressors of RNAi (VSR) able to inhibit Dicer activity and promote infection have been identified. Here, we explored the integrity and functional role of Dicer during FMDV infection. These studies showed that the FMDV-encoded Leader protease (Lpro) specifically cleaves Dicer at a conserved DExD/H helicase motif releasing the complete N-terminal helicase domain. Dicer cleavage by Lpro suppressed small hairpin RNA (shRNA)-induced RNAi in swine cells. Silencing of Dicer conferred increased susceptibility to an Lpro-deficient FMDV, revealing a Dicer-dependent antiviral effect which can be effectively counteracted by Lpro. This mutant generated a remarkably different profile of viral small RNAs (vsRNAs) in infected cells compared with the wild-type virus. Overall, we identified a viral mechanism of dampening or modulating antiviral defenses based on Dicer proteolytic degradation.

Indexed as

EndopeptidasesFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusRibonuclease IIIViral ProteinsAnimalsCell LineHost-Pathogen InteractionsHumansProteolysisRNA InterferenceRNA, Small InterferingRNA, ViralSwineEndopeptidasesleader proteinase, foot-and-mouth disease virusRibonuclease IIIRNA, Small InterferingRNA, ViralViral Proteins

Identifiers

PMID40614179
PMCPMC12227051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.